Rich Enough to Reduce Debt, Elan Again Pulls Drug-Delivery Unit Off the Block
This article was originally published in The Pink Sheet Daily
Executive Summary
Armed with cash from its blockbuster Alzheimer's deal with J&J, the drug maker says it can wait indefinitely to sell its profitable contract business.